Blood pressure control over time in childhood-onset systemic lupus erythematous

Lupus. 2018 Apr;27(4):657-664. doi: 10.1177/0961203317751061. Epub 2018 Jan 4.

Abstract

Introduction Hypertension (HTN) is prevalent in patients with systemic lupus erythematosus (SLE) and causes early cardiovascular aging and progression of renal and cardiac disease. The aim of this longitudinal retrospective study was to evaluate the prevalence of HTN, the follow-up blood pressure trends, and risk factors for HTN in a population-based cohort with childhood-onset SLE (cSLE). Methods Demographic and clinical data of consecutive visits from the baseline to the last visit were extracted from electronic medical records of patients with cSLE. Results A total of 110 patients with cSLE were identified with a median follow-up duration of 29.5 months; 19% had lupus nephritis (LN) at diagnosis. Further, 29% and 23% had HTN and preHTN at the baseline visit. Compared to those without HTN, patients with HTN had higher disease activity, obesity, more frequent LN, and lower eGFR. In multivariate analysis, the presence of LN, obesity, and high extra-renal disease activity were independent predictors of HTN at baseline. Conclusions While HTN is a known feature of LN, HTN is common and persistent in cSLE without LN, with about one-third of patients having uncontrolled elevated blood pressure almost three years after the onset of lupus. In addition to LN, obesity and high overall disease activity were independent predictors of HTN.

Keywords: Systemic lupus erythematosus; blood pressure; cardiovascular disease; hypertension; lupus nephritis.

MeSH terms

  • Adolescent
  • Age of Onset
  • Antihypertensive Agents / therapeutic use
  • Blood Pressure* / drug effects
  • Chi-Square Distribution
  • Child
  • Comorbidity
  • Electronic Health Records
  • Female
  • Glomerular Filtration Rate
  • Humans
  • Hypertension / diagnosis
  • Hypertension / drug therapy
  • Hypertension / epidemiology*
  • Hypertension / physiopathology
  • Kidney / physiopathology
  • Kidney Diseases / physiopathology
  • Logistic Models
  • Longitudinal Studies
  • Lupus Erythematosus, Systemic / diagnosis
  • Lupus Erythematosus, Systemic / epidemiology*
  • Lupus Nephritis / diagnosis
  • Lupus Nephritis / epidemiology*
  • Male
  • Multivariate Analysis
  • Obesity / epidemiology
  • Ohio / epidemiology
  • Prevalence
  • Retrospective Studies
  • Risk Factors
  • Time Factors

Substances

  • Antihypertensive Agents